#
Title
1

Temporal, Cell-Specific Angiopoietin-2 in CKD

2

Cardiovascular Effects of GLP-1 RA in Kidney Failure

3

ASN Kidney Translation Series: Artificial Intelligence in Nephrology

4

Subclinical Primary Aldosteronism and eGFR Decline

5

ASN Kidney Translation Series: Peritoneal Dialysis

6

PD Use in Health Service Areas, 2009–2020

7

ASN Kidney Translation Series: ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure

8

LCN2-Induced CLUH Inhibition Disrupts Mitochondria in Kidney

9

ASN Kidney Translation Series: Kidney Transplant Advances

10

Automatic Organ and Cyst Volumes in ADPKD

11

Coronary Disease Screening Prior to Kidney Transplant

12

ASN Kidney Translation Series: Advances in Glomerular Filtration Rate

13

Bone Marrow Inflammation Drives Glomerular Damage

14

ICD Code Accuracy for CVD in CKD

15

Dapagliflozin and HRQoL in Patients with CKD

16

ASN Kidney Translation Series: Glomerulonephritis

17

ASN Kidney Translation Series: ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives

18

RNA Sequencing of IgA Nephropathy Kidneys

19

Alternative Splicing and Polyadenylation in Glomerular Disease

20

ASN Kidney Translation Series: Cardiovascular-Kidney Connection

21

The PEER-HD Randomized Controlled Trial

22

Disaster Management in Kidney Care

23

Regulation of Renal Glucose Handling by mTORC2

24

Drug Screening in Drosophila Nephrocytes

25

ASN Kidney Translation Series: ADPKD Advances

26

Anticoagulation in Dialysis Recipients with Atrial Fibrillation

27

CASR Determines Renal Response to Hypercalcemia

28

ASN Kidney Translation Series: ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury

29

ASN Kidney Translation Series: Kidney Stones

30

Molecular Signature of NPCs in the Catshark

31

Acetazolamide and the Kidney in T1D

32

Kidney Protection by Acetylcholine

33

ASN Kidney Translation Series: Genetic Testing in Nephrology

34

JASN Welcomes Basic Science Research

35

ASN Kidney Translation Series: Novel Therapies for IgA Nephropathy

36

Polycystin-2 Regulates Natriuretic Peptide Production

37

ASN Kidney Translation Series: ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases

38

KLF15 Agonist in Kidney Disease

39

Stem Cells in Renovascular Disease

40

ASN Kidney Translation Series: Gender Equity in Nephrology

41

Complications of Uninephrectomy

42

JASN Welcomes Late-Breaking Clinical Trial Manuscript Submissions

43

sGC Activator Avenciguat for CKD

44

Absolute CKD Progression Risk

45

ASN Kidney Translation Series: PPI, Antivirals, and Cough Syrups: Nephrotoxins and Kidney Injury

46

Tubular Effect of Proteinuria

47

Set7 Regulates Glomerular Injury

48

Daprodustat and Heart Failure in CKD

49

Changes in ESKD Incidence

50

Dr. Briggs and Dr. Mehrotra discuss the next chapter for JASN

51

SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade

52

Kidney Transplant Registry Data: Advice for Users

53

Next Steps in Development of Mesenchymal Stem Cells as Possible Therapeutic for Kidney Disease

54

Historical Redlining and the Incidence of Kidney Failure in US Cities

55

Antibiotic Use & Kidney Stones and Sodium Bicarbonate & the Vascular Dysfunction of CKD

56

How Many Nephrons in a Human Kidney? A New Number and a Discussion of Why it Matters

57

The Angiopoietin-Tie 2 Pathway is Ischemic Kidney Injury

58

Urea and Uremia

59

Genomic Diagnostic Methods for CKD

60

Intensive BP Control and CKD Progression and Prognosis in Anti-GBM Disease

61

Pregnancy Risk for Kidney Patients; Cost Effectiveness Research in Dialysis

62

Use of Kidney Organoids to Study Steroid-Resistant Nephrotic Syndrome

63

Highlights in Renal Transplantation

64

Comparing Costs of Hemodialysis and Peritoneal Dialysis

65

Gender Differences in Care of CKD Patients

66

Climate Change: Implications for Nephrology

67

August 2022 JASN Highlights: Addressing CKD Progression and Hazards of Intradialytic Hypotension

68

Addressing Racial and Ethnic Disparities in Kidney Disease

69

Discontinuing Immunosuppressant Use after Allograft Failure: Do We Have the Answers?

70

A New Approach to Advance Care Planning for Dialysis Decisions: Deciding not to Decide

71

JASN May 2022 Highlights: Inflammation as a Driver of CKD Progression

72

Roxadustat and the Interpretation of Non-Inferiority

73

The Renal Framingham - CVD Prediction

74

Lowering GFR to Protect GFR!

75

Insights into Collapsing Glomerulopathy

76

The Immune Responses to COVID-19 in Transplant Patients

77

JASN November 2021 Issue Highlights

78

JASN October 2021 Issue Highlights

79

New Directions for Clinical Trials in Kidney Disease

80

JASN August 2021 Issue Highlights

81

Lost Opportunities for Kidney Transplant

82

The Extracellular Matrix in Development, Aging, and Disease

83

Vaccine Acceptability and Hemodialysis Patients

84

COVID-19 Mortality and the Tough Discussions about Advance Care Planning

85

New Insights into the Mechanisms of Kidney Disease: Understanding Hypercholesterolemia in CKD; ADAM10 and Immune Injury to the Podocyte Slit Diaphragm

86

JASN May 2022 Issue Highlights

87

JASN April 2021 Issue Highlights

88

JASN March 2021 Issue Highlights

89

JASN February 2021 Issue Highlights

90

JASN January 2021 Issue Highlights

91

A Conversation with Mark Knepper and Josie Briggs: Does SARS-CoV2 Infect the Kidney?

92

A Dialogue with Mahboob Rahman and Erin Barreto About Ambulatory Blood Pressure Monitoring in Patients with Chronic Kidney Disease

93

A Discussion with Andrew Malone and Madhav Menon: RNAseq and the Transplant Biopsy, What is New?

94

A Conversation with Deidre Crews and Tanjala Purnell about COVID-19, Structural Racism and Kidney Disease